What is AbbVie's coolsculpting — finite-lived intangible assets, net?

AbbVie (ABBV) reported coolsculpting — finite-lived intangible assets, net of $1.30B in Q4 2023.

What does coolsculpting — finite-lived intangible assets, net mean?

The current book value of Coolsculpting intangible assets after accounting for wear and tear or usage over time.

Discontinued — last reported Q4 '23

Products & Services · Finite-Lived Intangible Assets, Net

Coolsculpting — Finite-Lived Intangible Assets, Net

Analysis

StatementSegment

CategoryEfficiency

SignalHigher is better

VolatilityStable

First reportedQ4 2023

Last reportedQ4 2023Feb 20, 2026

Rolls up toIntangibles (Net)

How to read this metric

A steady decline is expected due to amortization, but a sharp drop may indicate an impairment charge, reflecting reduced expectations for the product's future revenue generation.

Detailed definition

This metric represents the carrying value of Coolsculpting-related intangible assets on the balance sheet, net of accumu...

Peer comparison

Comparable to 'Net Intangible Assets' or 'Product Rights' reported by peers in the medical device and aesthetics industry.

Metric ID: abbv_segment_coolsculpting_finite_lived_intangible_assets_net

Historical Data

1 periods

	Q4 '23
Value	$1.30B

Similar Metrics at Other Companies

CenteneCNC View metric

ViatrisVTRS View metric

BiogenBIIB View metric

Raymond James FinancialRJF View metric

Estee Lauder Companies Inc.EL View metric

Frequently Asked Questions

What is AbbVie's coolsculpting — finite-lived intangible assets, net?: AbbVie (ABBV) reported coolsculpting — finite-lived intangible assets, net of $1.30B in Q4 2023.
What does coolsculpting — finite-lived intangible assets, net mean?: The current book value of Coolsculpting intangible assets after accounting for wear and tear or usage over time.